| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 8 | |
| #2 | Mexico | 5 | |
| #3 | WIPO (World Intellectual Property Organization) | 5 | |
| #4 | Argentina | 4 | |
| #5 | Canada | 4 | |
| #6 | Australia | 3 | |
| #7 | Brazil | 3 | |
| #8 | Chile | 3 | |
| #9 | Peru | 3 | |
| #10 | United States | 3 | |
| #11 | Uruguay | 3 | |
| #12 | Dominican Republic | 1 | |
| #13 | Hungary | 1 | |
| #14 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Measuring microorganism processes | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Salas Eduardo | 25 |
| #2 | Castillo Sergio | 23 |
| #3 | Elosua Roberto | 23 |
| #4 | Ogorelkova Miroslava | 13 |
| #5 | Elosua Llanos Roberto | 13 |
| #6 | Marrugat De La Iglesia Jaume | 12 |
| #7 | Vila Joan S | 12 |
| #8 | Castillo Fernandez Sergio | 12 |
| #9 | Salgado Gomez Joan | 9 |
| #10 | Salas Perez-Rasilla Eduardo | 9 |
| Publication | Filing date | Title |
|---|---|---|
| WO2018215590A1 | Cancer-associated venous thromboembolic events | |
| US2018066313A1 | Thromboembolic disease markers | |
| AU2014314097A1 | Risk markers for cardiovascular disease in patients with chronic kidney disease | |
| EP2554679A1 | Genetic markers for cardiovascular disease risk assessment | |
| EP2535424A1 | SNPs associated with thromboemoblic disease | |
| EP2264183A1 | Risk markers for cardiovascular disease |